Pacific Biosciences Of California reported $301.96M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agilent USD 282.22M 478K Mar/2026
Bruker USD 152.22M 282K Mar/2026
Danaher USD 702.9M 4.8M Jun/2026
General Electric Aerospace USD 1.04B 5.77M Jun/2026
Illumina USD 151.3M 607K Jun/2026
Myriad Genetics USD 93.5M 400K Dec/2025
Pacific Biosciences Of California USD 301.96M 103K Dec/2025
Quidel USD 68.1M 200K Mar/2026
Revvity USD 111.8M 1.57M Mar/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
Standard Biotools USD 390.14M 3.76M Mar/2026
Thermo Fisher Scientific USD 371.62M 1000 Jun/2026
Waters USD 98.17M 89K Mar/2026